Crystalline forms of ( 3 S ) -3- [N- (N' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' - tetrafluorophenoxy) -4-oxopentanoic acid

Details for Australian Patent Application No. 2007330478 (hide)

International Classifications

Event Publications

18 June 2009 PCT application entered the National Phase

PCT publication WO2008/068615 Priority application(s): WO2008/068615

13 August 2009 Amendment Made

The nature of the amendment is: Amend the co-inventor name from Dimmock, Stuart to Dimock, Stuart

18 August 2011 Assignment before Grant

Pfizer Inc. The application has been assigned to IDUN Pharmaceuticals, Inc.

8 September 2011 Application Accepted

Published as AU-B-2007330478

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.